StockData
IN8bio, Inc. logo

IN8bio, Inc. (INAB) stock

INABNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.78−0.04 (-4.88%)

Close on Nov 18, 2026Market cap $7.69MP/E –Yield –

IN8bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

IN8bio's market cap was $8.59M on Nov 11, 2026, against $9.09M a year earlier. Over the last 5 years it ranged from $5.66M to $82.34M, with a median of $29.99M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.59M-20.0%
2025Dec 31, 2025$10.74M-10.8%
2024Dec 31, 2024$12.03M-72.7%
2023Dec 29, 2023$44.13M-22.0%
2022Dec 30, 2022$56.61M-31.3%
2021Dec 31, 2021$82.34M–

More IN8bio figures

See a number that looks wrong?